Schedule of Investments
ARK Innovation ETF
October 31, 2022 (Unaudited)
Investments | Shares | Value | ||||||
COMMON STOCKS–99.6% | ||||||||
Automobiles - 9.1% | ||||||||
Tesla, Inc.* | 3,082,407 | $ | 701,370,889 | |||||
Biotechnology - 22.5% | ||||||||
Beam Therapeutics, Inc.*† | 6,304,320 | 277,768,339 | ||||||
CRISPR Therapeutics AG (Switzerland)*† | 5,669,454 | 296,739,222 | ||||||
Exact Sciences Corp.*† | 11,225,550 | 390,424,629 | ||||||
Fate Therapeutics, Inc.*† | 7,116,257 | 148,872,097 | ||||||
Intellia Therapeutics, Inc.*† | 6,640,849 | 350,504,010 | ||||||
Twist Bioscience Corp.*† | 3,965,125 | 130,175,054 | ||||||
Veracyte, Inc.*† | 5,057,233 | 101,700,956 | ||||||
Verve Therapeutics, Inc.* | 867,096 | 32,689,519 | ||||||
Total Biotechnology | 1,728,873,826 | |||||||
Capital Markets - 7.4% | ||||||||
Coinbase Global, Inc., Class A* | 4,842,263 | 320,799,924 | ||||||
Robinhood Markets, Inc., Class A* | 21,331,593 | 249,153,006 | ||||||
Total Capital Markets | 569,952,930 | |||||||
Chemicals - 3.1% | ||||||||
Ginkgo Bioworks Holdings, Inc.*† | 85,385,419 | 233,102,194 | ||||||
Diversified Consumer Services - 0.5% | ||||||||
2U, Inc.*† | 6,364,869 | 39,398,539 | ||||||
Entertainment - 10.4% | ||||||||
ROBLOX Corp., Class A* | 6,527,573 | 292,043,616 | ||||||
Roku, Inc.*† | 9,132,303 | 507,208,109 | ||||||
Total Entertainment | 799,251,725 | |||||||
Health Care Equipment & Supplies - 0.6% | ||||||||
Cerus Corp.*† | 11,551,603 | 42,278,867 | ||||||
Health Care Providers & Services - 0.6% | ||||||||
Invitae Corp.*† | 18,675,068 | 48,181,675 | ||||||
Health Care Technology - 4.5% | ||||||||
Teladoc Health, Inc.*† | 11,648,337 | 345,256,709 | ||||||
Hotels, Restaurants & Leisure - 3.3% | ||||||||
DraftKings, Inc., Class A* | 15,849,104 | 250,415,843 | ||||||
IT Services - 13.0% | ||||||||
Block, Inc.* | 5,981,688 | 359,319,998 | ||||||
Shopify, Inc., Class A (Canada)* | 8,839,803 | 302,586,457 | ||||||
Twilio, Inc., Class A* | 4,515,306 | 335,803,307 | ||||||
Total IT Services | 997,709,762 | |||||||
Life Sciences Tools & Services - 2.7% | ||||||||
10X Genomics, Inc., Class A* | 3,198,323 | 86,930,419 | ||||||
Berkeley Lights, Inc.* | 348,569 | 773,823 | ||||||
Pacific Biosciences of California, Inc.*† | 14,456,285 | 122,011,045 | ||||||
Total Life Sciences Tools & Services | 209,715,287 | |||||||
Road & Rail - 0.4% | ||||||||
TuSimple Holdings, Inc., Class A* | 8,130,527 | 27,887,707 | ||||||
Semiconductors & Semiconductor Equipment - 1.2% | ||||||||
NVIDIA Corp. | 699,109 | 94,358,742 | ||||||
Software - 20.3% | ||||||||
Materialise NV (Belgium)*†(a) | 3,847,353 | 40,743,468 | ||||||
PagerDuty, Inc.*† | 8,066,421 | 201,176,540 | ||||||
UiPath, Inc., Class A*† | 27,628,980 | 349,506,597 | ||||||
Unity Software, Inc.* | 8,309,121 | 245,119,070 | ||||||
Zoom Video Communications, Inc., Class A* | 8,613,748 | 718,731,133 | ||||||
Total Software | 1,555,276,808 | |||||||
Total Common Stocks | ||||||||
(Cost $20,566,494,704) | 7,643,031,503 | |||||||
MONEY MARKET FUND–0.4% | ||||||||
Dreyfus Government Cash Management Fund, Institutional Shares, 2.91% (b) | ||||||||
(Cost $28,574,864) | 28,574,864 | 28,574,864 | ||||||
Total Investments–100.0% | ||||||||
(Cost $20,595,069,568) | 7,671,606,367 | |||||||
Other Assets in Excess of Liabilities–0.0%(c) | 1,796,368 | |||||||
Net Assets–100.0% | $ | 7,673,402,735 |
* | Non-income producing security |
† | Affiliated security |
(a) | American Depositary Receipt |
(b) | Rate shown represents annualized 7-day yield as of October 31, 2022. |
(c) | Less than 0.05% |
Schedule of Investments (continued)
ARK Innovation ETF
October 31, 2022 (Unaudited)
Affiliated Issuer Transactions
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities, or a company that is under common ownership or control. Period to date transactions with companies which are or were affiliates are as follows:
Value ($) at 7/31/2022 | Purchases Cost ($) | Sales Proceeds ($) | Net Realized Gain/(Loss) ($) | Net Change in Unrealized Appreciation (Depreciation) ($) | Dividend Income ($) | Capital Gain Distributions ($) | Number of Shares at 10/31/2022 | Value ($) at 10/31/2022 | ||||||||||||||||||||||||||||
Common Stocks — 47.2% | ||||||||||||||||||||||||||||||||||||
Biotechnology — 22.1% | ||||||||||||||||||||||||||||||||||||
Beam Therapeutics, Inc. | ||||||||||||||||||||||||||||||||||||
425,310,301 | 119,015,917 | (148,805,640 | ) | (321,482 | ) | (117,430,757 | ) | – | – | 6,304,320 | 277,768,339 | |||||||||||||||||||||||||
CRISPR Therapeutics AG | ||||||||||||||||||||||||||||||||||||
475,632,825 | 131,846,649 | (188,062,275 | ) | (19,484,643 | ) | (103,193,334 | ) | – | – | 5,669,454 | 296,739,222 | |||||||||||||||||||||||||
Exact Sciences Corp. | ||||||||||||||||||||||||||||||||||||
453,419,254 | 192,604,855 | (155,646,874 | ) | 1,521,579 | (101,474,185 | ) | – | – | 11,225,550 | 390,424,629 | ||||||||||||||||||||||||||
Fate Therapeutics, Inc. | ||||||||||||||||||||||||||||||||||||
218,139,689 | 79,290,584 | (83,182,705 | ) | (21,874,437 | ) | (43,501,034 | ) | – | – | 7,116,257 | 148,872,097 | |||||||||||||||||||||||||
Intellia Therapeutics, Inc. | ||||||||||||||||||||||||||||||||||||
430,810,590 | 152,892,033 | (155,996,164 | ) | (7,677,215 | ) | (69,525,234 | ) | – | – | 6,640,849 | 350,504,010 | |||||||||||||||||||||||||
Twist Bioscience Corp. | ||||||||||||||||||||||||||||||||||||
178,879,891 | 54,029,962 | (62,568,222 | ) | 6,650,677 | (46,817,254 | ) | – | – | 3,965,125 | 130,175,054 | ||||||||||||||||||||||||||
Veracyte, Inc. | ||||||||||||||||||||||||||||||||||||
137,390,204 | 34,364,568 | (40,312,857 | ) | (1,056,524 | ) | (28,684,435 | ) | – | – | 5,057,233 | 101,700,956 | |||||||||||||||||||||||||
Chemicals — 3.0% | ||||||||||||||||||||||||||||||||||||
Ginkgo Bioworks Holdings, Inc. | ||||||||||||||||||||||||||||||||||||
200,265,720 | 129,918,575 | (87,716,329 | ) | 9,973,708 | (19,339,480 | ) | – | – | 85,385,419 | 233,102,194 | ||||||||||||||||||||||||||
Diversified Consumer Services — 0.5% | ||||||||||||||||||||||||||||||||||||
2U, Inc. | ||||||||||||||||||||||||||||||||||||
64,267,072 | 15,544,997 | (17,889,554 | ) | (1,918,881 | ) | (20,605,095 | ) | – | – | 6,364,869 | 39,398,539 | |||||||||||||||||||||||||
Entertainment — 6.6% | ||||||||||||||||||||||||||||||||||||
Roku, Inc. | ||||||||||||||||||||||||||||||||||||
597,014,440 | 223,953,718 | (234,525,011 | ) | 2,153,108 | (81,388,146 | ) | – | – | 9,132,303 | 507,208,109 | ||||||||||||||||||||||||||
Health Care Equipment & Supplies — 0.6% | ||||||||||||||||||||||||||||||||||||
Cerus Corp. | ||||||||||||||||||||||||||||||||||||
64,337,431 | 16,454,479 | (19,270,656 | ) | (507,985 | ) | (18,734,402 | ) | – | – | 11,551,603 | 42,278,867 | |||||||||||||||||||||||||
Health Care Providers & Services — 0.6% | ||||||||||||||||||||||||||||||||||||
Invitae Corp. | ||||||||||||||||||||||||||||||||||||
35,214,655 | 25,351,635 | (23,489,409 | ) | 15,851 | 11,088,943 | – | – | 18,675,068 | 48,181,675 | |||||||||||||||||||||||||||
Signify Health, Inc. ^ | ||||||||||||||||||||||||||||||||||||
228,647,398 | 35,405,697 | (394,871,541 | ) | 75,598,078 | 55,220,368 | – | – | – | – | |||||||||||||||||||||||||||
Health Care Technology — 4.5% | ||||||||||||||||||||||||||||||||||||
Teladoc Health, Inc. | ||||||||||||||||||||||||||||||||||||
439,542,710 | 138,583,453 | (146,678,933 | ) | (4,782,128 | ) | (81,408,393 | ) | – | – | 11,648,337 | 345,256,709 | |||||||||||||||||||||||||
Life Sciences Tools & Services — 1.6% | ||||||||||||||||||||||||||||||||||||
Berkeley Lights, Inc. ^ | ||||||||||||||||||||||||||||||||||||
18,250,247 | 3,207,184 | (15,879,009 | ) | (138,857,178 | ) | 134,052,579 | – | – | 348,569 | 773,823 | ||||||||||||||||||||||||||
Compugen Ltd. ^ | ||||||||||||||||||||||||||||||||||||
9,521,030 | 456,284 | (8,458,001 | ) | (51,068,846 | ) | 49,549,533 | – | – | – | – | ||||||||||||||||||||||||||
Pacific Biosciences of California, Inc. | ||||||||||||||||||||||||||||||||||||
61,525,177 | 37,552,103 | (35,014,832 | ) | 1,988,445 | 55,960,152 | – | – | 14,456,285 | 122,011,045 | |||||||||||||||||||||||||||
Road & Rail — 0.0% | ||||||||||||||||||||||||||||||||||||
TuSimple Holdings, Inc. ^ | ||||||||||||||||||||||||||||||||||||
107,440,372 | 34,493,286 | (44,684,639 | ) | (118,971,229 | ) | 49,609,917 | – | – | 8,130,527 | 27,887,707 | ||||||||||||||||||||||||||
Software — 7.7% | ||||||||||||||||||||||||||||||||||||
Materialise NV | ||||||||||||||||||||||||||||||||||||
59,636,430 | 16,601,647 | (21,698,481 | ) | (9,999,488 | ) | (3,796,640 | ) | – | – | 3,847,353 | 40,743,468 | |||||||||||||||||||||||||
PagerDuty, Inc. | ||||||||||||||||||||||||||||||||||||
215,727,928 | 69,670,578 | (78,422,848 | ) | (157,876 | ) | (5,641,242 | ) | – | – | 8,066,421 | 201,176,540 |
Schedule of Investments (continued)
ARK Innovation ETF
October 31, 2022 (Unaudited)
Value ($) at 7/31/2022 | Purchases Cost ($) | Sales Proceeds ($) | Net Realized Gain/(Loss) ($) | Net Change in Unrealized Appreciation (Depreciation) ($) | Dividend Income ($) | Capital Gain Distributions ($) | Number of Shares at 10/31/2022 | Value ($) at 10/31/2022 | ||||||||||||||||||||||||||||
UiPath, Inc. | ||||||||||||||||||||||||||||||||||||
413,196,381 | 200,036,903 | (147,513,376 | ) | 3,557,493 | (119,770,804 | ) | – | – | 27,628,980 | 349,506,597 | ||||||||||||||||||||||||||
$ | 4,834,169,745 | $ | 1,711,275,107 | $ | (2,110,687,356 | ) | $ | (275,218,973 | ) | $ | (505,828,943 | ) | $ | – | $ | – | 251,214,522 | $ | 3,653,709,580 |
^ | As of October 31, 2022, the company was no longer considered to be an affiliated security. |
Schedule of Investments (continued)
ARK Innovation ETF
October 31, 2022 (Unaudited)
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 — Quoted prices in active markets for identical assets.
• Level 2 — Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 — Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of October 31, 2022, based upon the three levels defined above:
ARK Innovation ETF | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Assets | ||||||||||||||||
Common Stocks‡ | $ | 7,643,031,503 | $ | – | $ | – | $ | 7,643,031,503 | ||||||||
Money Market Fund | 28,574,864 | – | – | 28,574,864 | ||||||||||||
Total | $ | 7,671,606,367 | $ | – | $ | – | $ | 7,671,606,367 |
‡ | Please refer to the Schedule of Investments to view securities segregated by industry type. |